Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma

Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma

Yezi Chen,1,2,* Xiaoqin Luo,2,3,* Yun Liu,4 Yunlei Zou,1,2 Shiqi Yang,1,2 Chaoqi Liu,1,2 Yun Zhao1,2 1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China; 2Medical College of China Three Gorges Universit...

Full description

Bibliographic Details
Main Authors: Chen Y, Luo X, Liu Y, Zou Y, Yang S, Liu C, Zhao Y
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:International Journal of Nanomedicine
Subjects:
ultrasound targeted nanobubble destruction
tumor immune therapy
immune checkpoint inhibitors
immunogenic cell death
drug delivery
Online Access:https://www.dovepress.com/targeted-nanobubbles-of-pd-l1-mab-combined-with-doxorubicin-as-a-syner-peer-reviewed-fulltext-article-IJN

Internet

https://www.dovepress.com/targeted-nanobubbles-of-pd-l1-mab-combined-with-doxorubicin-as-a-syner-peer-reviewed-fulltext-article-IJN

Similar Items